Literature DB >> 26162922

Correlation of Radiologic with Surgical Peritoneal Cancer Index Scores in Patients with Pseudomyxoma Peritonei and Peritoneal Carcinomatosis: How Well Can We Predict Resectability?

Kristina Flicek1, Awais Ashfaq1, C Dan Johnson2, Christine Menias2, Sanjay Bagaria3, Nabil Wasif4.   

Abstract

INTRODUCTION: Pseudomyxoma peritonei (PMP) and peritoneal carcinomatosis (PC) arises from primary or secondary peritoneal cancer and can be treated with complete surgical removal of disease. Suitability for surgery is based on a peritoneal cancer index (PCI), with a PCI ≥ 20 representing unresectable disease. AIMS: Compare preoperative imaging with surgical findings based on PCI.
METHODS: All cases of patients with PMP and PC undergoing cytoreductive surgery ± hyperthermic intraperitoneal chemotherapy (HIPEC) between 2010 and 2014 were included. Two staff radiologists blinded to surgical PCI scores retrospectively reviewed imaging studies to calculate corresponding radiologic PCI scores for each patient. Correlation between radiologic PCI and surgical PCI, as obtained from operative reports, was assessed using Spearman's rho correlation coefficients. Preoperative assessment of a PCI cutoff of 20 on imaging was compared with actual surgical PCI using sensitivity, specificity, and positive and negative predictive values.
RESULTS: Forty-two patients had a mean surgical PCI ± SEM score of 15.1 ± 1.3 and mean radiologic PCI of 15.5 ± 1.5. The most common tumor histologies were appendiceal (60 %) and colon (33 %) adenocarcinoma and were of low tumor grade (67 %). Correlation between individual radiologists and surgical PCI was 0.59 and 0.62, respectively (all p < 0.001). When mean radiologic PCI was used, this correlation with surgical PCI improved to 0.64 and to 0.65 when good quality studies only were considered (all p < 0.001). Radiologic PCI score had a sensitivity of 76 %, a specificity of 69 %, positive predictive value of 85 %, and a negative predictive value of 56 % when compared with the surgical PCI. In patients with a radiologic PCI score ≥ 20, 6/13 (46 %) still achieved adequate cytoreduction.
CONCLUSIONS: Good quality cross-sectional imaging, combined with overreading and formal assessment of all components of the PCI score yields the best correlation with actual surgical findings. Although preoperative assessment of PCI ≥ 20 was reasonably accurate, using this cutoff to assess resectability is problematic as almost half of these patients were still able to undergo adequate cytoreduction. Better assessment of resectability is needed preop, either by refinement of the PCI criteria or routine staging laparoscopy.

Entities:  

Keywords:  Cytoreductive surgery; Imaging; Peritoneal cancer index; Peritoneal carcinomatosis

Mesh:

Year:  2015        PMID: 26162922     DOI: 10.1007/s11605-015-2880-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  33 in total

1.  Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.

Authors:  Rodrigo Gomes da Silva; Paul H Sugarbaker
Journal:  J Am Coll Surg       Date:  2006-10-25       Impact factor: 6.113

2.  Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  E de Bree; W Koops; R Kröger; S van Ruth; V J Verwaal; F A N Zoetmulder
Journal:  Eur J Surg Oncol       Date:  2005-11-14       Impact factor: 4.424

Review 3.  Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment.

Authors:  Mario Valle; Orietta Federici; Alfredo Garofalo
Journal:  Surg Oncol Clin N Am       Date:  2012-10       Impact factor: 3.495

4.  Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy.

Authors:  Thomas J Miner; Jinru Shia; David P Jaques; David S Klimstra; Murray F Brennan; Daniel G Coit
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging.

Authors:  J Davies; A G Chalmers; H M Sue-Ling; J May; G V Miller; I G Martin; D Johnston
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

6.  Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin.

Authors:  Haney Youssef; Christopher Newman; Kandiah Chandrakumaran; Faheez Mohamed; Tom D Cecil; Brendan J Moran
Journal:  Dis Colon Rectum       Date:  2011-03       Impact factor: 4.585

7.  Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.

Authors:  Terence C Chua; Tristan D Yan; Michelle E Smigielski; Katherine J Zhu; Keh M Ng; Jing Zhao; David L Morris
Journal:  Ann Surg Oncol       Date:  2009-04-23       Impact factor: 5.344

8.  Evaluation of computed tomography in patients with peritoneal carcinomatosis.

Authors:  P Jacquet; J S Jelinek; M A Steves; P H Sugarbaker
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

Review 9.  Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence.

Authors:  A Mukherjee; A Parvaiz; T D Cecil; B J Moran
Journal:  Eur J Gynaecol Oncol       Date:  2004       Impact factor: 0.196

10.  Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.

Authors:  V J Verwaal; H van Tinteren; S van Ruth; F A N Zoetmulder
Journal:  Br J Surg       Date:  2004-06       Impact factor: 6.939

View more
  10 in total

1.  Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.

Authors:  Masatoshi Hotta; Ryogo Minamimoto; Yoshimasa Gohda; Toru Igari; Hideaki Yano
Journal:  Eur Radiol       Date:  2019-03-14       Impact factor: 5.315

Review 2.  The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy.

Authors:  Alexandra Gangi; Rupen Shah
Journal:  Ann Surg Oncol       Date:  2021-12-01       Impact factor: 5.344

Review 3.  Peritoneal disease: key imaging findings that help in the differential diagnosis.

Authors:  Nuno M F Campos; Vânia Almeida; Luís Curvo Semedo
Journal:  Br J Radiol       Date:  2021-11-23       Impact factor: 3.039

Review 4.  Imaging of pre- and post-cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pediatric intraperitoneal malignancy.

Authors:  Nathan C Hull; Candace F Granberg; Patricio C Gargollo; Paul G Thacker
Journal:  Pediatr Radiol       Date:  2022-10-07

5.  Authors' Reply to Wu et al. "Comment on: Repeat Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Recurrences is Safe and Efficacious".

Authors:  Shachar Laks; Almog Ben-Yaacov; Mohammad Adileh; Aviram Nissan
Journal:  Ann Surg Oncol       Date:  2021-04-03       Impact factor: 5.344

Review 6.  Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research.

Authors:  Foteini Stefania Koumpa; Diamantis Xylas; Maciej Konopka; Dieter Galea; Kirill Veselkov; Anthony Antoniou; Akash Mehta; Reza Mirnezami
Journal:  Gastroenterol Res Pract       Date:  2019-04-01       Impact factor: 2.260

7.  Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.

Authors:  S Hallam; R Tyler; M Price; A Beggs; H Youssef
Journal:  BJS Open       Date:  2019-06-27

8.  The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries.

Authors:  Sissel Ravn; Christian F Christiansen; Rikke H Hagemann-Madsen; Victor J Verwaal; Lene H Iversen
Journal:  Clin Epidemiol       Date:  2020-03-27       Impact factor: 4.790

9.  Radiomics analysis based on CT's greater omental caking for predicting pathological grading of pseudomyxoma peritonei.

Authors:  Nan Zhou; Ruixue Dou; Xichao Zhai; Jingyang Fang; Jiajun Wang; Ruiqing Ma; Jingxu Xu; Bin Cui; Lei Liang
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.379

10.  Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis.

Authors:  Jason M Foster; Richard L Sleightholm; Steve Wahlmeier; Brian Loggie; Poonam Sharma; Asish Patel
Journal:  World J Surg Oncol       Date:  2016-09-13       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.